trending Market Intelligence /marketintelligence/en/news-insights/trending/xUMlFergNAmTJEt1EOphrg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Roche again delays $4.3B Spark Therapeutics takeover amid regulatory scrutiny

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021


Roche again delays $4.3B Spark Therapeutics takeover amid regulatory scrutiny

Roche Holding AG again extended its $4.3 billion takeover offer for Spark Therapeutics Inc. to give additional time to U.S. and U.K. regulators to examine the deal.

In March, Roche launched a buyout offer to acquire all outstanding shares of the Philadelphia-based gene-therapy maker for $114.50 apiece. Roche has already extended the offer period several times from the initial April 3 deadline.

The Swiss drugmaker said the offer will now expire at 5 p.m. ET on Dec. 16, unless further extended.